Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pizzuti

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Journal of Personalized Medicine|December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient SeriesArmando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Oncogenesis|July 23, 2018
Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancerFrancesca De Nicola, Frauke Goeman, Matteo Pallocca, et al.
Journal of Cancer|March 10, 2016
Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer PatientsPatrizia Vici, Laura Pizzuti, Luigi Di Lauro, et al.
Cancers|August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.
Breast Cancer Research and Treatment|September 20, 2014
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER studyPatrizia Vici, Laura Pizzuti, Clara Natoli, et al.
Journal of Cellular Physiology|May 26, 2017
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancerLaura Pizzuti, Domenico Sergi, Chiara Mandoj, et al.
International Journal of Cancer|February 25, 2017
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapyLivia Ronchetti, Elisa Melucci, Francesca De Nicola, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2021
KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to ImmunotherapyStefano Scalera, Marco Mazzotta, Giacomo Corleone, et al.
Oncoimmunology|September 18, 2018
The clinical significance of PD-L1 in advanced gastric cancer is dependent on Simonetta Buglioni, Elisa Melucci, Francesca Sperati, et al.
Journal of Clinical Medicine|April 30, 2021
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future PerspectivesEriseld Krasniqi, Maddalena Barba, Aldo Venuti, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Journal of Personalized Medicine|December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient SeriesArmando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Oncogenesis|July 23, 2018
Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancerFrancesca De Nicola, Frauke Goeman, Matteo Pallocca, et al.
Journal of Cancer|March 10, 2016
Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer PatientsPatrizia Vici, Laura Pizzuti, Luigi Di Lauro, et al.
Cancers|August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.
Breast Cancer Research and Treatment|September 20, 2014
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER studyPatrizia Vici, Laura Pizzuti, Clara Natoli, et al.
Journal of Cellular Physiology|May 26, 2017
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancerLaura Pizzuti, Domenico Sergi, Chiara Mandoj, et al.
International Journal of Cancer|February 25, 2017
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapyLivia Ronchetti, Elisa Melucci, Francesca De Nicola, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2021
KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to ImmunotherapyStefano Scalera, Marco Mazzotta, Giacomo Corleone, et al.
Oncoimmunology|September 18, 2018
The clinical significance of PD-L1 in advanced gastric cancer is dependent on Simonetta Buglioni, Elisa Melucci, Francesca Sperati, et al.
Journal of Clinical Medicine|April 30, 2021
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future PerspectivesEriseld Krasniqi, Maddalena Barba, Aldo Venuti, et al.
Pageof 12